Grifols’ Fesilty Review Shows US FDA Still Can Deliver Timely Approvals

 
• By Cole Werble
  
The Fesility approval showed CBER still is willing to work through issues with a sponsor. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from United States